Quantitative analyses showed a significant increase in CD4+ (P = 0.00085) and in CD8+ (P = 0.0034) TILs in most analysed paired tumours after CAN-3110 treatment (Fig. 2a and Supplementary Table 2c). This evidence concerns the gene CD8A and neoplasm.